SkinBioTherapeutics warns on profit amid probe into CEO
British skin-health company SkinBioTherapeutics said today that misrepresentations in its accounts uncovered in an ongoing investigation into its former CEO will leave annual earnings "significantly below" market expectations.
Business
• 16 Feb
